Archive: 2026/03

Interchangeability: When Biosimilars Can Be Substituted Automatically in the U.S.

In the U.S., only 10 biosimilars have FDA interchangeability status, allowing pharmacists to swap them for brand-name biologics without doctor approval. Learn how this works, why it matters for cost and safety, and why state laws make it a confusing patchwork.